Low-dose-dependent carcinogenic potential of 2-amino-3- methylimidazo[4,5-f]quinoline in the immunodeficient (SCID) mouse colon

Nutrition and Cancer

Volumn 34, Issue 2, 1999, Pages 220-228

  Salim, Elsayed I ^a   Wanibuchi, Hideki ^a   Yamamoto, Shinji ^a   Morimura, Keiichirou ^a   Mori, Satoru ^b   Makino, Susumu ^b   Nomura, Taisei ^c   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; AROMATIC AMINE; BROXURIDINE; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; CARCINOGENICITY; COLON CANCER; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; INCIDENCE; MALE; MOUSE; NONHUMAN; PRECANCER;

ANIMALIA;

EID: 0032711037     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC3402_14     Document Type: Article

References (65)

1. Skog, K, Steineck, G, Augustsson, K, and Jagerstad, M: Effect of cooking temperature on the formation of heterocyclic amines in fried meat products and pan residues. Carcinogenesis 16, 861-867, 1995.
2. Doll, R, and Peto, R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. JNCI 66, 1191-1308, 1981.
3. Yamashita, M, Wakabayashi, K, Nagao, M, Sato, S, Yamaizumi, Z, et al.: Detection of 2-amino-3-methylimidazo[4,5-f]quinoline in cigarette smoke condensate. Jpn J Cancer Res 77, 419-422, 1986.
4. Manabe, S, Suzuki, H, Wada, O, and Ueki, A: Detection of the carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in beer and wine. Carcinogenesis 14, 899-901, 1993.
5. Felton, JS, and Knize, MG: Occurrence, identification and bacterial mutagenicity of heterocyclic amines in cooked food. Mutat Res 259, 205-217, 1991.
6. Ohgaki, H, Kusama, K, Matsukura, N, Morino, K, Hasegawa, H, et al.: Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 5, 921-1924, 1984.
7. Dooley, KL, Von-Tungeln, LS, Bucci, T, Fu, PP, and Kadlubar, FF: Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP and MelQx in the neonatal B6C3F1 male mouse. Cancer Lett 62, 205-209, 1992.
8. Takayama, S, Nakatsuru, Y, Masuda, M, Ohgaki, H, Sato, S, et al.: Demonstration of carcinogenicity in F344 rats of 2-amino-3-methylimidazo [4,5-f]quinoline from broiled sardine, fried beef and beef extract. Gann 75, 467-470, 1984.
9. Tanaka, T, Barnes, WS, Williams, GM, and Weisburger, JH: Multipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Jpn J Cancer Res 76, 570-576, 1985.
10. Adamson, RH, Thorgeirsson, UP, Snyderwine, EG, Thorgeirsson, SS, Reeves, J, et al.: Carcinogenicity of 2-amino-3-methylimidazo[4,5f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn J Cancer Res 81, 10-14, 1990.
11. Schut, HA, Herzog, CR, and Cummings, DA: Accumulation of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in tissues and white blood cells of the Fischer-344 rat after multiple oral dosing. Carcinogenesis 15, 1467-1470, 1994.
12. 32P-Postlabelling Assay to the Inhibition of 2-Amino-3-Methylimidazo[4,5-f]Quinoline (IQ)-DNA Adduct Formation by Dietary Fatty Acids. Lyon, France: Int Agency Res Cancer, 1993, pp 181-188. (IARC Sci Publ 124)
13. Kristiansen, E, Meyer, O, and Thorup, I: The ability of two cooked food mutagens to induce aberrant crypt foci in mice. Eur J Cancer Prev 6, 53-57, 1997.
14. Kristiansen, E: The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice. Cancer Lett 110, 187-192, 1996.
15. Yamazoe, Y, Shimada, M, Kamataki, T, and Kato, R: Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res 43, 5768-5774, 1983.
16. Butler, MA, Iwazaki, M, Guengerich, FP, and Kadlubar, FF: Human cytochrome P-450PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86, 7696-7700, 1989.
17. Snyderwine, EG, Roller, PP, Adamson, RH, Sato, S, and Thorgeirsson, SS: Reaction of N-hydroxylamine and N-acetoxy derivatives of 2-amino-3-methylimidazolo[4,5-f]quinoline with DNA. Synthesis and identification of N-(deoxyguanosine-8-yl)-IQ. Carcinogenesis 9, 1061-1065, 1988.
18. Turesky, RJ, Lang, NP, Butler, MA, Teitel, CH, and Kadlubar, FF: Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12, 1839-1845, 1991.
19. Hammons, GJ, Milton, D, Stepps, K, Guengerich, FP, Tukey, RH, et al.: Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis 18, 851-854, 1997.
20. Steineck, G, Gerhardsson de Verdier, M, and Overvik, E: The epidemiological evidence concerning intake of mutagenic activity from the fried surface and the risk of cancer cannot justify preventive measures. Eur J Cancer Prev 2, 293-300, 1993.
21. Bosma, GC, Custer, RP, and Bosma, MJ: A severe combined immunodeficiency mutation in the mouse. Nature 301, 527-530, 1983.
22. Uckun, FM: Severe combined immunodeficient mouse models of human leukemia. Blood 88, 1135-1146, 1996.
23. Nomura, T, Nakajima, H, Hongyo, T, Taniguchi, E, Fukuda, K, et al.: Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice. Cancer Res 57, 2081-2084, 1997.
24. Nacht, M, Strasser, A, Chan, YR, Harris, AW, Schlissel, M, et al.: Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev 10, 2055-2066, 1996.
25. Bird, RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37, 147-151, 1987.
26. Yamashita, N, Minamoto, T, Onda, M, and Esumi, H: Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn J Cancer Res 85, 692-698, 1994.
27. Hsu, SM, Raine, L, and Fanger, H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75, 734-738, 1981.
28. Bird, RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93, 55-71, 1995.
29. Pretlow, TP, O'Riordan, MA, Somich, GA, Amini, SB, and Pretlow, TG: Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13, 1509-1512, 1992.
30. Losi, L, Roncucci, L, di Gregorio, C, de Leon, MP, and Benhattar, J: K-ras and p53 mutations in human colorectal aberrant crypt foci. J Pathol 178, 259-263, 1996.
31. Tachino, N, Hayashi, R, Liew, C, Bailey, G, and Dashwood, R: Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts in the rat. Mol Carcinog 12, 187-192, 1995.
32. Smith, AJ, Stern, HS, Penner, M, Hay, K, Mitri, A, et al.: Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54, 5527-5530, 1994.
33. Stopera, SA, Davie, JR, and Bird, RP: Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer. Carcinogenesis 13, 573-578, 1992.
34. Tudek, B, Bird, RP, and Bruce, WR: Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res 49, 1236-1240, 1989.
35. Tanaka, T, Kawabata, K, Kakumoto, M, Makita, H, Hara, A, et al.: Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis 18, 2155-2161, 1997.
36. Morimura, K, Salim, El, Yamamoto, S, Wanibuchi, H, and Fukushima, S: Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mouse treated with low dose 2-amino-3-methylimidazo[4,5-f]quinoline. Cancer Lett. 138: 81-85, 1999.
37. Stavric, B: Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review. Food Chem Toxicol 32, 977-994, 1994.
38. Wakabayashi, K, Nagao, M, Esumi, H, and Sugimura, T: Food-derived mutagens and carcinogens. Cancer Res 52 Suppl, 2092s-2098s, 1992.
39. Layton, DW, Bogen, KT, Knize, MG, Hatch, FT, Johnson, VM, et al.: Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16, 39-52, 1995.
40. Kulkarni, N, Zang, E, Kelloff, G, and Reddy, BS: Effect of the chemopreventive agents piroxicam and D,L-α-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis. Carcinogenesis 13, 995-1000, 1992.
41. Nagao, M, and Sugimura, T: Carcinogenic factors in food with relevance to colon cancer development. Mutat Res 290, 43-51, 1993.
42. 14C]IQ and MeIQx in the mouse. Toxicol Lett 44, 183-190, 1988.
43. Percy, DH, and Barta, JR: Spontaneous and experimental infections in scid and scid/beige mice. Lab Anim Sci 43, 127-132, 1993.
44. Rumney, CJ, Rowland, IR, and O'Neill, IK: Conversion of IQ to 7-OHIQ by gut microflora. Nutr Cancer 19, 67-76, 1993.
45. Kajikawa, A, Umemoto, A, Hamada, K, Tanaka, M, Kinnouchi, T, et al.: Mucosa-preferential DNA adduct formation by 2-amino-3-methylimidazo [4,5-f]quinoline in the rat colonic wall. Cancer Res 55, 2769-2773, 1995.
46. Nerurkar, PV, Schut, HA, Anderson, LM, Riggs, CW, Fornwald, LW, et al.: Ahr locus phenotype in congenic mice influences hepatic and pulmonary DNA adduct levels of 2-amino-3-methylimidazo[4,5-f]quinoline in the absence of cytochrome P450 induction. Mol Pharmacol 49, 874-881, 1996.
47. Davis, CD, Dacquel, EJ, Schut, HA, Thorgeirsson, SS, and Snyderwine, EG: In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta™ mice and c-myc/lacZ double transgenic mice. Mutat Res 356, 287-296, 1996.
48. Nerurkar, PV, Schut, HA, Anderson, LM, Riggs, CW, Snyderwine, EG, et al.: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in colon, bladder and kidney of congenic mice differing in Ah responsiveness and N-acetyltransferase genotype. Cancer Res 55, 3043-3049, 1995.
49. Schut, HA, Cummings, DA, Sarnle, MH, Josyula, S, and Friesen, MD: DNA adducts of heterocyclic amines: formation, removal and inhibition by dietary components. Mutat Res 376, 185-194, 1997.
50. Fulop, GM, and Phillips, RA: The scid mutation in mice causes a general defect in DNA repair. Nature 347, 479-482, 1990.
51. Tanaka, T, Yamagami, T, Oka, Y, Nomura, T, and Sugiyama, H: The scid mutation in mice causes defects in the repair system for both double-strand DNA breaks and DNA cross-links. Mutat Res 288, 277-280, 1993.
52. Danska, JS, Holland, DP, Mariathasan, S, Williams, KM, and Guidos, CJ: Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes. Mol Cell Biol 16, 5507-5517, 1996.
53. Gurley, KE, and Kemp, CJ: p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice. Carcinogenesis 17, 2537-2542, 1996.
54. Evans, JW, Liu, XF, Kirchgessner, CU, and Brown, JM: Induction and repair of chromosome aberrations in scid cells measured by premature chromosome condensation. Radiat Res 145, 39-46, 1996.
55. Nevaldine, B, Longo, JA, and Hahn, PJ: The scid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks. Radiat Res 147, 535-540, 1997.
56. Matsumura, Y, and Tarin, D: Fingerprinting survey of various human tumors and their metastases. Cancer Res 52, 2174-2179, 1992.
57. Ledwith, BJ, Joslyn, DJ, Troilo, P, Leander, KR, Clair, JH, et al.: Induction of minisatellite DNA rearrangements by genotoxic carcinogens in mouse liver tumors. Carcinogenesis 16, 1167-1172, 1995.
58. Imai, H, Nakagama, H, Komatsu, K, Shiraishi, T, Fukuda, H, et al.: Minisatellite instability in severe combined immunodeficiency mouse cells. Proc Natl Acad Sci USA 94, 10817-10820, 1997.
59. Ochiai, M, Imai, H, Sugimura, T, Nagao, M, and Nakagama, H: Susceptibility to colon carcinogenesis induced by azoxymethane in SCID mice (abstr). Proc Jpn Cancer Assoc 89 Suppl, 273, 1998.
60. Dudley, ME, Sundberg, JP, and Roopenian, DC: Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mutation. Int J Cancer 65, 249-253, 1996.
61. Disney, JE, Barth, AL, and Shultz, LD: Defective repair of radiation-induced chromosomal damage in scid/scid mice. Cytogenet Cell Genet 59, 39-44, 1992.
62. Gurley, KE, Vo, K, and Kemp, CJ: DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice. Cancer Res 58, 3111-3115, 1998.
63. Modrich, P: Mismatch repair, genetic stability, and cancer. Science 266, 1959-1960, 1994.
64. Hartwell, L: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71, 543-546, 1992.
65. Hall, M, She, MN, Wild, D, Fasshauer, I, Hewer, A, et al.: Tissue distribution of DNA adducts in CDF1 mice fed 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). Carcinogenesis 11, 1005-1011, 1990.